CT Imaging Study for Knee Osteotomy (CISKO)
CISKO
Computerized Tomography (CT) Scan Study of Bone Healing Following Open Wedge Proximal Tibial Osteotomy [CT Imaging Study for Knee Osteotomy (CISKO)]
2 other identifiers
interventional
10
1 country
1
Brief Summary
Malalignment of the knee joint causes arthritis in later life. Currently there are three surgical ways to treat knee arthritis: total knee replacement, partial knee replacement, and high tibial osteotomy (HTO). The former two very much focus on treating the effect of malalignment, i.e. removing the arthritic joint. However, HTO addresses the cause of the arthritis, namely the joint malalignment. This preserves the patient's joint and it means that a patient will start using the unaffected part of the knee joint more. HTO involves cutting a wedge out the tibia to correct the alignment of that bone with the knee joint, to redistribute load from the affected medial part to lateral part. To keep the tibia in the new position, a medical nail device is attached to keep it in place and allow new bone to regenerate within the wedge. Currently, the market leader for HTO is the TomoFix (by DePuySynthes company) plate and nail device. As the name suggests, TomoFix is fixed at surgery and therefore the change in bone angle cannot be changed afterwards. It does mean that patients can be weight-bearing on the affected leg soon after the HTO procedure. A new CE-marked device is being tested in an interventional trial; it is produced by Ellipse Technologies. This device is an extendable nail and inserted intramedullary; following surgery the nail is tend slowly extended over a period of time until the bone correction is satisfactory. The CISKO imaging study will assess whether there is a difference between the TomoFix and Ellipse system in terms of bone regeneration in the tibial wedge by performing a CT-scan at 3 and 6 months post-operatively. This will be quantified by two independent radiological reports. A secondary objective is to investigate patient satisfaction and also patient pain levels at these time intervals. The degree of bone healing is usually the main factor holding clinicians back when it comes to advising patients on what activities they can return to post-operatively. A difference in bone healing between the two systems may impact on the advice clinicians can give patients regarding recommencing more intense activities such as recreational sports, which ultimately could positively impact patients' health and well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 15, 2016
CompletedFirst Posted
Study publicly available on registry
March 24, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedApril 8, 2016
April 1, 2016
10 months
March 15, 2016
April 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Healing score
Healing of the osteotomy site after final correction as assessed by two independent radiology reports based on visual assessment of the CT imaging
3 months
Secondary Outcomes (2)
Patient satisfaction score
6 months
Change in KOOS score
6 months
Study Arms (2)
CT scan Ellipse
EXPERIMENTALNew medical device for high tibial osteotomy
CT scan Tomofix
ACTIVE COMPARATOREstablished medical device for high tibial osteotomy
Interventions
Eligibility Criteria
You may qualify if:
- Provision of written informed consent
- Males
- Mental capacity
You may not qualify if:
- Under age (\< 18 years)
- Patients lacking mental capacity.
- Females
- Current use of nicotine products.
- Patients who cannot understand English and therefore cannot be consented.
- Varus deformity greater than 10°
- Flexion contracture greater than 15°
- Knee flexion under 90°
- Medial/lateral tibial subluxation over 1 cm
- Medial bone loss of over 3 mm
- Inflammatory arthritis (including use of methotrexate)
- Arthritis in the lateral compartment
- Patella baja
- Weight over 114 kg
- Severe patella femoral symptoms
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- North Cumbria University Hospitals NHS Trustlead
- NuVasivecollaborator
Study Sites (1)
Cumberland Infirmary
Carlisle, Cumbria, CA2 7HY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chris Hafner, PhD
NuVasive
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2016
First Posted
March 24, 2016
Study Start
March 1, 2016
Primary Completion
January 1, 2017
Study Completion
February 1, 2017
Last Updated
April 8, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will share
Results to be published in peer-reviewed scientific journal